Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
1098 | 2757 | 26.3 | 60% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
1696 | 6158 | HEPATITIS E VIRUS//HEPATITIS A//HEPATITIS E |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | HEPATITIS A | Author keyword | 483 | 61% | 19% | 512 |
2 | HEPATITIS A VACCINE | Author keyword | 207 | 84% | 4% | 112 |
3 | HEPATITIS A VIRUS | Author keyword | 167 | 46% | 10% | 274 |
4 | HAV | Author keyword | 45 | 45% | 3% | 75 |
5 | HEPATITIS A VACCINES | Author keyword | 29 | 88% | 1% | 14 |
6 | HEPATITIS A VACCINATION | Author keyword | 27 | 76% | 1% | 19 |
7 | ANTI HAV | Author keyword | 25 | 75% | 1% | 18 |
8 | INACTIVATED HEPATITIS A VACCINE | Author keyword | 21 | 90% | 0% | 9 |
9 | HAV VACCINE | Author keyword | 15 | 88% | 0% | 7 |
10 | HAV INFECTION | Author keyword | 12 | 86% | 0% | 6 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | HEPATITIS A | 483 | 61% | 19% | 512 | Search HEPATITIS+A | Search HEPATITIS+A |
2 | HEPATITIS A VACCINE | 207 | 84% | 4% | 112 | Search HEPATITIS+A+VACCINE | Search HEPATITIS+A+VACCINE |
3 | HEPATITIS A VIRUS | 167 | 46% | 10% | 274 | Search HEPATITIS+A+VIRUS | Search HEPATITIS+A+VIRUS |
4 | HAV | 45 | 45% | 3% | 75 | Search HAV | Search HAV |
5 | HEPATITIS A VACCINES | 29 | 88% | 1% | 14 | Search HEPATITIS+A+VACCINES | Search HEPATITIS+A+VACCINES |
6 | HEPATITIS A VACCINATION | 27 | 76% | 1% | 19 | Search HEPATITIS+A+VACCINATION | Search HEPATITIS+A+VACCINATION |
7 | ANTI HAV | 25 | 75% | 1% | 18 | Search ANTI+HAV | Search ANTI+HAV |
8 | INACTIVATED HEPATITIS A VACCINE | 21 | 90% | 0% | 9 | Search INACTIVATED+HEPATITIS+A+VACCINE | Search INACTIVATED+HEPATITIS+A+VACCINE |
9 | HAV VACCINE | 15 | 88% | 0% | 7 | Search HAV+VACCINE | Search HAV+VACCINE |
10 | HAV INFECTION | 12 | 86% | 0% | 6 | Search HAV+INFECTION | Search HAV+INFECTION |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | A VACCINE | 133 | 60% | 5% | 145 |
2 | SHIFTING EPIDEMIOLOGY | 60 | 100% | 1% | 20 |
3 | SUBGENOTYPES IA | 56 | 100% | 1% | 19 |
4 | COMMUNITY WIDE OUTBREAK | 54 | 68% | 2% | 47 |
5 | HAV | 51 | 79% | 1% | 33 |
6 | A VACCINATION | 36 | 79% | 1% | 23 |
7 | INACTIVATED VIROSOME | 35 | 86% | 1% | 18 |
8 | CO CIRCULATION | 29 | 67% | 1% | 26 |
9 | ATTENUATED HEPATITIS | 27 | 83% | 1% | 15 |
10 | H2 STRAIN | 26 | 100% | 0% | 11 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Hepatitis A virus: Host interactions, molecular epidemiology and evolution | 2014 | 8 | 211 | 54% |
Hepatitis A: Clinical Manifestations and Management | 2010 | 35 | 21 | 90% |
Declining hepatitis A seroprevalence: a global review and analysis | 2004 | 151 | 165 | 77% |
Diagnosis of hepatitis A virus infection: a molecular approach | 2006 | 93 | 209 | 74% |
Long-term protective effects of hepatitis A vaccines. A systematic review | 2012 | 14 | 27 | 96% |
Hepatitis A in the era of vaccination | 2006 | 68 | 90 | 91% |
Costing Infectious Disease Outbreaks for Economic Evaluation A Review for Hepatitis A | 2009 | 22 | 25 | 92% |
Increasing Incidence of Hepatitis A in Korean Adults | 2010 | 19 | 28 | 100% |
Hepatitis A: Old and new | 2001 | 145 | 161 | 70% |
Hepatitis A virus in the Middle East and North Africa region: a new challenge | 2014 | 3 | 50 | 74% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | HEPATITIS BRANCH | 6 | 23% | 0.9% | 24 |
2 | REFERENCE VIRUS TRANSMISS ENTER | 6 | 100% | 0.1% | 4 |
3 | ENTER VIRUS | 5 | 30% | 0.5% | 13 |
4 | JE 2437 | 4 | 75% | 0.1% | 3 |
5 | UNIDAD INMUNOVIROL | 4 | 75% | 0.1% | 3 |
6 | HEPATITIS RELATED EMERGING AGENTS | 4 | 46% | 0.2% | 6 |
7 | DESENVOLVIMENTO TECNOL VIROL | 4 | 36% | 0.3% | 8 |
8 | UP EA1156 | 3 | 100% | 0.1% | 3 |
9 | EVALUAT VACCINAT | 2 | 11% | 0.8% | 21 |
10 | GRP VIRUS ENTER | 2 | 67% | 0.1% | 2 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000121018 | REPRINT SERV//HEPATITIS VACCINATION//EDMOND DE ROTH ILD FDN |
2 | 0.0000111636 | POSTVIRAL ENCEPHALITIS//RELAPSING HEPATITIS//RHEUMATOL METAB BONE JOINT DIS |
3 | 0.0000060823 | HEPATITIS E VIRUS//HEPATITIS E//HEPATITIS E VIRUS HEV |
4 | 0.0000057815 | HEPATITIS B VACCINE//HEPATITIS B//HEPATITIS B VACCINATION |
5 | 0.0000054869 | HIV 1 EPIDEMIOLOGY//HIV AIDS PREVENT PROGRAM//ARMY PERSONNEL |
6 | 0.0000050955 | IMMUNOLOGICAL AGENTS//INT MED PROGRAMME//CLINICAL PREDICTIONS |
7 | 0.0000049338 | VIROSOMES//FUSOGENIC LIPOSOME//VIROSOME |
8 | 0.0000046361 | HEPATITIS B VIRUS ASSOCIATED GLOMERULONEPHRITIS//HBV ASSOCIATED NEPHROPATHY//HEPATITIS B SURFACE ANTIGENEMIA |
9 | 0.0000042066 | 3C PROTEASE//PICORNAVIRUS//PROTEINASE 3C |
10 | 0.0000041129 | BENAVIDES CANC//COLORECTOANAL SURG//HEPATITIS A ACUTE |